Table 2: Immunotherapeutic drugs.
Anti–CTLA-4
Anti-PD-1 Antibody
TVEC
Ipilimumab
Nivolumab, Lambrolizumab, MPDL3280A
CTLA-4: cytotoxic T-lymphocyte antigen 4; PD-1: Programmed Cell Death Protein 1